viralmedi
central
nervou
system
cn
diseas
complex
spectrum
clinic
syndrom
result
viral
tropism
individu
immun
respons
genet
suscept
patient
epidemiolog
pathogen
constantli
influenc
avail
nonavail
health
care
servic
prevent
strategi
process
global
rapid
movement
peopl
anim
product
complic
natur
disast
war
chang
lifestyl
effect
neurotrop
virus
discuss
background
epidemiolog
pathogenesi
chain
event
point
departur
viru
enter
bodi
spread
reach
differ
site
cn
bloodbrain
barrier
bloodcerebrospin
fluid
barrier
overcom
captiv
mechan
differ
virus
settl
prefer
site
site
sidestep
initi
immun
surveil
phase
injuri
commenc
cytopath
effect
virus
elicit
paraand
postinfecti
inflammatori
respons
viciou
circl
continu
damag
viral
entri
inflamm
result
process
mere
inflamm
intens
inflamm
differ
clinic
syndrom
identifi
interpret
specif
appropri
epidemiolog
background
clinician
face
challeng
problemat
manag
decis
await
result
grave
ill
patient
differenti
diagnost
consider
taken
account
establish
diagnosi
twotier
process
first
requir
integr
cerebrospin
fluid
find
imag
result
electrophysiolog
studi
serolog
ancillari
blood
test
exampl
full
blood
count
liver
function
test
appropri
microbiolog
investig
correl
clinic
condit
patient
treatment
initi
soon
possibl
gener
treatment
principl
stabil
maintain
vital
function
crucial
empir
treatment
initi
soon
possibl
usual
includ
broadspectrum
antibiot
thirdgener
cephalosporin
acyclovir
soon
specif
etiolog
exclud
antibiot
stop
use
acyclovir
discuss
last
section
chapter
specif
characterist
neurotrop
viral
famili
summar
children
often
admit
differenti
diagnosi
possibl
viralassoci
central
nervou
system
cn
infect
virus
affect
cn
mani
differ
way
clinic
manifest
may
overlap
result
spectrum
syndrom
sejvar
eloqu
summar
differ
altern
viralmedi
diseas
cn
respons
syndrom
acut
phase
patient
may
present
mening
enceph
myeliti
combin
multipl
region
affect
eg
meningoencpeh
encephalomyel
vascul
promin
compon
specif
diseas
process
patient
may
present
focal
sign
due
area
infarct
long
term
reactiv
dormant
infect
episod
recurr
observ
relentless
chronic
neurodegen
process
may
occur
caus
subacut
scleros
panenceph
sspe
slow
virus
congenit
infect
cytomegaloviru
cmv
rubella
may
result
neurodevelopment
disord
chronic
natur
cn
may
also
affect
secondarili
viralinduc
immunemedi
attack
cn
indirectli
seen
liver
failureassoci
encephalopathi
due
viral
hepat
rey
syndrom
precipit
salicyl
treatment
children
influenza
varicellazost
viru
vzv
infect
howev
confirm
specif
diagnosi
challeng
clinic
present
well
special
investig
often
nonspecif
aim
chapter
outlin
fact
known
mani
conundrum
still
face
aid
clinician
make
inform
decis
manag
patient
gener
principl
applic
virusassoci
cn
infect
discuss
first
part
chapter
specif
virus
interest
end
although
often
difficult
appli
specif
case
definit
variou
viralrel
cn
syndrom
pedant
clinic
set
definit
ultim
import
patient
manag
research
definit
base
anatom
site
site
affect
sejvar
et
al
publish
case
definit
enceph
myeliti
acut
dissemin
encephalomyel
adem
behalf
brighton
collabor
enceph
work
group
britton
et
al
compar
differ
definit
enceph
includ
brighton
definit
use
five
larg
epidemiolog
studi
purpos
chapter
differ
definit
collat
essenc
key
featur
overlap
repres
main
clinic
syndrom
relat
anatom
site
affect
broader
clinic
terminolog
use
definit
explain
section
clinic
manifest
enceph
inflamm
brain
tissu
infiltr
inflammatori
cell
perivascular
cuf
therefor
essenc
histopatholog
diagnosi
brain
biopsi
impract
readili
avail
clinic
approach
thu
follow
case
definit
formul
number
excel
epidemiolog
studi
definit
vari
slightli
exampl
age
patient
inclus
criteria
practic
definit
enceph
depend
presenc
clinic
sign
due
involv
brain
tissu
manifest
encephalopathi
period
least
hour
andor
specif
neurolog
featur
evid
inflamm
indic
inflamm
fever
cerebrospin
fluid
csf
pleocytosi
electroencephalogram
eeg
neuroimag
find
consist
enceph
one
use
way
think
infect
fever
infect
clinic
sign
enceph
usual
non
specif
subtl
howev
immun
suppress
patient
may
subtl
often
also
chronic
encephalopathi
due
metabol
caus
toxin
neurolog
disord
system
infect
caus
wide
varieti
etiolog
factor
includ
virus
bacteria
parasit
atyp
bacteria
immunemedi
process
specif
etiolog
confirm
case
diseas
cours
acut
subacut
chronic
determin
immun
statu
patient
virus
respons
subacut
chronic
present
immunocompromis
patient
measl
viru
caus
inclus
bodi
enceph
vzv
caus
multifoc
leukoencephalopathi
cmv
herp
simplex
viru
hsv
type
human
herp
viru
hhv
type
enterovirus
john
cunningham
viru
bk
viru
caus
progress
multifoc
leukoencephalopathi
human
immunodefici
viru
hiv
immun
compet
patient
john
cunningham
viru
bk
viru
also
caus
progress
multifoc
leukoencephalopathi
wherea
measl
viru
caus
sspe
contrast
viral
enceph
brain
tissu
involv
viral
mening
patient
associ
encephalopathi
myeliti
present
triad
fever
headach
sign
mening
irrit
viral
mening
also
refer
asept
mening
bacteri
cultur
neg
mening
suspect
antibiot
administ
lumbar
punctur
lp
done
often
mild
diseas
favor
outcom
complet
recoveri
within
day
enterovirus
identifi
asept
mening
case
brain
parenchyma
mening
affect
refer
meningoenceph
often
difficult
assess
sign
mening
irrit
encephalopath
patient
confirm
mening
involv
myeliti
impli
inflamm
spinal
cord
parenchyma
present
usual
anterior
horn
cell
virus
implic
enterovirus
arbovirus
vzv
polioviru
coxsacki
virusa
b
brain
parenchyma
spinal
cord
affect
call
encephalomyel
patient
present
acut
flaccid
paralysi
transvers
myeliti
postinfecti
demyelin
patient
show
evid
viral
infect
myelopathi
diffus
nonspecif
involv
spinal
cord
caus
human
tcell
lymphotrop
viru
htlv
ii
hiv
rare
occas
hsv
cmv
enterovirus
htlvi
caus
tropic
spastic
paraparesi
htlviassoci
myelopathi
although
usual
present
later
life
around
fourth
fifth
decad
observ
younger
patient
onset
diseas
slow
progress
associ
backach
typic
spare
arm
leg
affect
clinic
sign
stiff
spastic
hyperreflexia
dysesthesia
posit
babinski
sign
posterior
column
often
involv
loss
posit
vibrat
sens
similar
present
observ
number
south
african
clinician
unpublish
data
seen
children
infect
present
spastic
diplegia
bowel
bladder
involv
magnet
reson
imag
mri
find
brain
spinal
cord
normal
unclear
whether
may
perhap
overlap
hivassoci
vacuolar
myelopathi
patient
also
present
spastic
paraparesi
weak
exceed
degre
spastic
hyperreflexia
posit
babinski
sign
atax
gait
dysmetria
bowel
bladder
incontin
present
posit
vibrat
sens
also
affect
macroscop
examin
spinal
cord
dura
mater
normal
loss
myelin
later
posterior
column
spongi
degener
microvacuol
white
matter
although
adem
one
immunemedi
encephalitid
refer
regularli
pediatr
therefor
merit
singl
set
context
enceph
monophas
syndrom
focal
dissemin
demyelin
inflamm
brain
parenchyma
also
regard
one
cn
demyelin
condit
includ
transvers
myeliti
optic
neuriti
acut
hemorrhag
leukoenceph
multipl
sclerosi
immunolog
basi
usual
preced
infect
vaccin
encephalitisadem
work
group
emphas
fact
encephalomyel
adem
occur
administr
inactiv
compon
live
vaccin
inevit
result
vaccin
may
temporarili
associ
clinic
featur
overlap
significantli
enceph
essenc
enceph
predominantli
grey
matter
problem
result
cytopath
effect
cell
bodi
cortex
basal
ganglia
thalami
present
chang
sensorium
seizur
oppos
adem
primarili
white
matter
diseas
featur
white
matter
diseas
demyelin
spastic
optic
neuriti
andor
atrophi
ataxia
neuropathi
myelopathi
occasion
seizur
sensorium
affect
lesser
extent
mild
pleocytosi
may
present
oligoclon
band
less
common
less
mri
help
identifi
demyelin
adem
absenc
specif
biomark
adem
diagnost
criteria
formul
diagnosi
adem
confirm
five
follow
criteria
met
first
episod
presum
inflammatori
demyelin
disord
result
multifoc
cn
manifest
encephalopathi
without
fever
mri
abnorm
lesion
predominantli
cerebr
white
matter
lesion
larg
diffus
poorli
demarc
rare
case
lesion
may
present
white
matter
thalami
basal
ganglia
may
also
affect
mri
show
new
lesion
month
reason
possibl
etiolog
extrem
import
diagnos
promptli
aggress
treatment
corticosteroid
immun
modulatori
drug
shown
promis
result
first
line
treatment
includ
steroid
intraven
immunoglobulin
andor
plasma
exchang
second
line
therapi
azathioprin
cyclophosphamid
rituximab
treatment
center
rituximab
use
firstlin
treatment
brain
stem
enceph
rhombenceph
result
paraneoplast
syndrom
bacteri
viral
infect
virus
implic
enterovirus
specif
flavivirus
alphavirus
rabi
patient
present
typic
brain
stem
symptom
includ
lower
cranial
nerv
palsi
myoclonu
respiratori
drive
disturb
autonom
dysfunct
lockedin
syndrom
mri
chang
brain
stem
basal
enhanc
gadolinium
contrast
bickerstaff
enceph
classic
triad
symptom
abnorm
mental
statu
bilater
extern
ophthalmoplegia
ataxia
relat
millerfish
syndrom
collect
refer
clinician
antibodi
syndrom
igg
highli
specif
condit
immunemedi
encephalitid
form
broad
group
disord
includ
adem
recent
describ
group
encephalitid
associ
antibodi
protein
synaps
cell
surfac
neuron
antibodi
intracellular
antigen
specif
refer
autoimmun
enceph
potenti
treatabl
demyelin
disord
present
autoimmun
enceph
two
entiti
cooccur
must
rather
investig
separ
seen
expans
spectrum
singl
diseas
constant
discoveri
new
antibodi
past
decad
reveal
novel
mechan
pathogenesi
alter
memori
cognit
behavior
psychosi
seizur
movement
disord
detail
discuss
differ
antibodi
fall
beyond
scope
chapter
mani
frequent
associ
diseas
manifest
adult
leypoldt
et
al
review
great
detail
multicent
studi
england
etiolog
enceph
studi
immunemedi
etiolog
identifi
patient
california
enceph
project
frequenc
antinmethyldaspart
receptor
antinmdar
enceph
four
time
higher
viralmedi
enceph
patient
younger
year
although
antinmdar
enceph
associ
tumor
mostli
ovarian
teratoma
seldom
present
children
younger
year
complic
matter
even
also
found
herp
simplex
enceph
hse
abl
trigger
autoimmun
enceph
synapt
autoimmun
choreoathetosi
posths
autoimmun
enceph
rather
primari
viral
enceph
consid
patient
present
movement
disord
psychiatr
disturb
psychosi
catatonia
abnorm
behavior
associ
clinic
featur
may
divers
may
includ
seizur
languag
disturb
chang
level
conscious
autonom
disturb
fever
may
present
cours
diseas
case
may
histori
prodrom
flulik
symptom
headach
reactiv
vzv
skin
lesion
may
may
present
antinmdar
enceph
rabi
might
consid
differenti
diagnosi
patient
may
also
sever
agit
hypersaliv
dyskinesia
standard
diagnost
test
use
correl
clinic
fact
make
preliminari
diagnosi
order
initi
treatment
await
specif
confirmatori
test
result
csf
reveal
mild
pleocytosi
normal
glucos
mildli
elev
protein
mri
use
specif
find
relat
variou
antibodi
mri
antinmdar
enceph
normal
case
rest
may
nonspecif
find
best
seen
invers
recoveri
flair
mri
imag
demonstr
cortic
subcort
chang
brain
posterior
fossa
transient
mening
enhanc
demyelin
also
observ
mri
rabi
contrast
may
show
chang
basal
ganglia
thalamu
gray
matter
dorsal
brain
stem
central
region
spinal
cord
limbic
enceph
usual
elderli
patient
rather
children
unior
bilater
involv
medial
aspect
tempor
lobe
demonstr
imag
diffus
weight
imag
normal
mening
enhanc
frontal
occipit
pariet
lobe
children
affect
may
extens
mri
abnorm
gold
standard
confirm
diagnosi
prove
presenc
specif
antibodi
absenc
autoantibodi
exclud
diagnosi
import
test
antibodi
serum
well
csf
antibodi
may
detect
csf
furthermor
csf
serum
antibodi
differ
clinic
present
usual
correl
csf
antibodi
addit
concentr
antibodi
csf
serum
may
vari
fewer
fals
posit
neg
result
determin
antibodi
csf
serum
epidemiolog
cn
viral
infect
constantli
chang
scene
new
virus
emerg
old
one
reemerg
complex
influenc
interplay
three
constitu
epidemiolog
triad
name
host
agent
environ
modern
constant
popul
growth
increas
popul
densiti
transmiss
infecti
agent
human
easier
zoonot
transmiss
also
favor
within
dens
urban
commun
social
behaviour
involv
increas
promiscu
easier
method
travel
exposur
exot
pet
virus
spread
great
eas
advanc
health
care
use
chemotherapi
immunosuppress
drug
transplant
patient
opportunist
infect
emerg
food
industri
becom
massproduct
orient
favor
foodborn
outbreak
natur
evolut
virus
may
increas
virul
organ
natur
disast
war
respons
breakdown
infrastructur
well
deliber
biolog
warfar
contribut
emerg
reemerg
spread
virus
difficult
compar
incid
preval
case
definit
use
differ
studi
vari
studi
reflect
endem
diseas
industri
countri
anoth
contribut
factor
complic
agreement
incid
preval
enceph
countri
notifi
diseas
britton
et
al
mention
incid
rang
per
report
england
sweden
usa
highest
rate
document
infant
less
year
age
hospit
admiss
children
due
enceph
decreas
period
year
australia
averag
hospit
rate
signific
decreas
varicella
enceph
explain
good
varicella
vaccin
coverag
contrast
increas
ademrel
enceph
document
ademrel
enceph
account
encephalitisrel
admiss
mani
virus
associ
cn
infect
tabl
summar
classif
common
virus
gener
accept
hsv
vzv
enterovirus
group
respons
cn
infect
children
neurotrop
virus
abl
caus
diseas
brain
chain
event
must
happen
swanson
mcgavern
outlin
current
understand
process
clearli
first
viru
enter
host
happen
inhal
ingest
skin
virus
mump
uncommon
occasion
common
measl
spread
via
droplet
inhal
reach
mucou
membran
upper
respiratori
tract
fecalor
rout
ingest
way
virus
enterovirus
enter
alimentari
tract
mucos
membran
virus
pass
epitheli
barrier
caus
infect
lymphoid
tissu
oropharynx
gut
insect
bite
abras
wound
creat
back
door
virus
enter
bodi
via
skin
langerhan
cell
carri
arbovirus
deliv
insect
bite
adjac
lymph
node
second
step
virus
way
reach
cn
spread
via
one
two
main
rout
blood
peripher
nerv
virus
either
float
brain
bloodstream
transport
white
blood
cell
trojan
hors
epstein
barr
viru
monocyt
vzv
migrat
keratinocyt
peripher
sensori
neuron
reach
trigemin
ganglion
latent
year
reactiv
dendrit
olfactori
nerv
direct
contact
mucosa
nose
offer
uniqu
port
entri
nipah
viru
influenza
viru
rabi
viru
case
dog
bite
rabi
viru
first
infect
myocyt
migrat
via
peripher
somat
nerv
follow
bbb
bloodbrainburri
bcsfb
blood
cerebrospin
fluid
barrier
third
step
closer
proxim
brain
parenchyma
viru
overcom
bloodbrain
barrier
bbb
bloodcerebrospin
fluid
barrier
bcsfb
protect
brain
creat
physic
metabol
transport
barrier
bbb
lumen
blood
vessel
brain
parenchyma
bcsfb
csf
apic
choroid
plexu
blood
vessel
permeabl
barrier
regul
tight
junction
adher
junction
tight
junction
complex
differ
protein
adhes
molecul
wherea
adher
junction
transmembran
cadherin
name
calcium
depend
adhes
link
cytoskeleton
virus
enter
bbb
whilst
coxsacki
chikungunya
viru
mump
viru
may
also
use
bcsfb
port
entri
six
differ
possibl
mechan
virus
cross
barrier
viruscarri
white
blood
cell
squeez
endotheli
cell
deposit
virus
brain
parenchyma
virus
enter
vascular
endotheli
cell
directli
cross
csf
open
pore
choroid
plexu
provid
direct
entri
virus
cn
bbb
intact
circumventricular
organ
exampl
area
postrema
lamina
terminali
form
ideal
site
virus
enter
cn
cn
lymphat
system
newli
describ
louveau
et
al
mening
lymphat
vessel
act
reservoir
leukocyt
groundbreak
discoveri
may
play
import
role
futur
explan
pathogenesi
cn
infect
barrier
disrupt
direct
cytotox
effect
pathogen
secondari
inflammatori
mediat
step
virus
enter
brain
difficult
detect
result
hide
cell
almost
invulner
immun
control
bbb
act
strong
immunolog
barrier
hamper
migrat
leukocyt
parenchyma
bcsf
regard
select
gate
primarili
respons
immun
surveil
cn
step
five
phase
injuri
hallmark
cascad
event
start
direct
cytopath
effect
paraand
postinfecti
inflammatori
respons
follow
respons
uniqu
specif
virus
influenc
viral
tropism
viral
tropism
specif
viru
specif
cell
type
host
neurotrop
viral
tropism
summar
tabl
exampl
john
cunningham
viru
affect
oligodendrocyt
therefor
myelin
product
compromis
cytopath
effect
virus
elicit
mere
brain
inflamm
intens
brain
inflamm
breakdown
bbb
allow
entranc
virus
addit
repair
mechan
restrict
due
limit
blood
suppli
brain
depend
cell
humoralmedi
immun
interstitium
constantli
patrol
microglia
antigen
present
weakli
develop
apoptosi
follow
inflamm
intensifi
cascad
may
complic
autoimmun
mediat
mechan
viral
infect
cn
result
spectrum
complex
neurolog
syndrom
therefor
clinic
manifest
must
alway
interpret
context
relat
specif
patient
consid
demograph
epidemiolog
individu
immun
statu
sign
mening
irrit
includ
neck
stiff
photophobia
posit
kernig
brudzinski
sign
encephalopathi
chang
mental
state
patient
character
alter
level
conscious
may
refer
anyth
continuum
lethargi
coma
alter
behavior
person
result
diffus
cortic
involv
newonset
psychosi
like
associ
autoimmun
enceph
viral
infect
focal
neurolog
sign
depend
specif
area
cn
may
affect
focal
cortic
sign
may
includ
exampl
aphasia
alexia
cortic
blind
motor
area
affect
motor
weak
may
present
abnorm
sensat
experienc
case
affect
sensori
cortex
cranial
nerv
fallout
visual
defect
common
deep
tendon
reflex
may
either
absent
brisk
primit
reflex
may
appear
cerebellar
involv
manifest
nystagmu
dysmetria
ataxia
dysdiadochokinesia
utmost
import
diagnos
rais
intracrani
pressur
icp
clinic
pressur
may
normal
viral
mening
elev
enceph
infant
may
bulg
fontanel
splay
sutur
sunset
eye
vomit
sever
irrit
lethargi
may
progress
coma
older
children
may
headach
vomit
cranial
nerv
iv
vi
palsi
cush
triad
elev
blood
pressur
slow
puls
respiratori
slow
coma
papilledema
papilledema
take
day
develop
may
absent
initi
stage
less
experienc
clinician
may
difficult
identifi
papilledema
sign
rais
icp
case
may
help
assess
postur
decort
decerebr
respiratori
pattern
pupillari
respons
seizur
common
viral
enceph
often
subtl
intract
case
may
evolv
statu
epilepticu
even
nonconvuls
statu
epilepticu
patient
present
newonset
statu
epilepticu
viral
caus
consid
patient
viral
enceph
may
electroclin
dissoci
motor
activ
seizur
visibl
detect
eeg
subtl
clinic
sign
seizur
bitten
tongu
injuri
twitch
eyelid
corner
mouth
failur
control
seizur
inevit
increas
metabol
activ
result
acidosi
vasodil
increas
icp
flaccid
paralysi
occur
anterior
horn
cell
affect
associ
polio
flavivirus
rabi
also
present
rapid
ascend
weak
mani
virus
caus
multisystem
involv
care
examin
alway
made
possibl
associ
manifest
may
assist
clinician
select
appropri
special
investig
varieti
skin
manifest
associ
neurotrop
virus
vesicular
rash
found
hsv
vzv
enterovirus
coxsacki
viru
may
also
accompani
rash
palm
hand
sole
feet
insid
mouth
inflam
oral
mucosa
refer
herpangina
often
associ
coxsacki
viru
hsv
adenoviru
slap
cheek
appear
associ
fever
headach
due
fifth
diseas
also
call
erythema
infectiosum
caus
human
parvoviru
roseola
infantum
sixth
diseas
morbiliform
rash
caus
eschar
tick
bite
may
hidden
hairlin
groin
finger
toe
even
ear
canal
measl
typic
maculopapular
rash
cardiac
manifest
patient
cn
viral
infect
either
primari
secondari
phenomena
primari
cardiac
involv
caus
virus
neurotrop
cardiotrop
featur
caus
myocard
cardiotrop
virus
ev
coxsacki
viru
adenoviru
hiv
human
parvoviru
epsteinbarr
viru
hypotens
arrhythmia
may
result
brain
stem
enceph
subtl
manifest
seizur
paramyxovirida
influenza
virus
may
caus
enceph
preced
respiratori
symptom
initi
believ
occur
rare
occas
becom
evid
respiratori
virus
increasingli
becom
relev
context
cnsassoci
infect
coronaviru
respons
common
cold
link
fatal
enceph
child
immunocompromis
enterovirus
human
parechoviru
rotaviru
caus
gastrointestin
symptom
may
also
affect
cn
mump
often
associ
parot
abdomin
pain
due
pancreat
orchiti
patient
cmv
epsteinbarr
virusassoci
hepat
may
elev
liver
enzym
myositi
common
symptom
influenza
infect
diagnosi
cn
viral
infect
confirm
specif
etiolog
tediou
process
often
veil
clinic
diagnost
uncertainti
alongsid
bed
grave
ill
patient
suspect
cn
infect
clinician
await
confirmatori
result
inevit
differenti
diagnos
consid
exclud
background
inform
histori
clinic
examin
crucial
key
question
necessari
draft
list
possibl
etiolog
age
patient
patient
live
child
vaccin
child
immunocompromis
children
affect
travel
histori
possibl
exposur
tick
mosquito
site
cn
involv
may
guid
clinician
toward
possibl
etiolog
child
encephalopathi
four
group
condit
exclud
name
infect
outsid
cn
toxin
autoimmun
metabol
disord
persist
metabol
acidosi
may
clue
underli
metabol
disord
respiratori
acidosi
consequ
hypoventil
associ
decreas
level
conscious
encephalopathi
associ
movement
disord
uncommon
uncompl
viral
enceph
present
autoimmun
enceph
adem
streptococc
infect
mycoplasma
infect
consid
differenti
diagnos
lymphocyt
pleocytosi
csf
asept
mening
partial
treat
mening
tubercul
mening
hiv
encephalopathi
often
overlook
neighborhood
syndrom
frequent
associ
mastoid
lymphocytosi
blood
support
viral
etiolog
cranial
nerv
involv
patient
encephalopathi
hse
tubercul
mening
rais
icp
bickerstaff
brain
stem
enceph
miller
fischer
syndrom
consid
hydrocephalu
associ
enceph
rather
complic
mening
caus
bacteria
tubercul
fungi
cryptococcu
brain
biopsi
gold
standard
confirm
viral
enceph
invas
unfeas
center
variou
investig
thu
develop
use
first
tier
investig
stereotact
brain
biopsi
place
diagnosi
remain
unabl
confirm
week
altern
consid
provid
perform
experienc
neurosurgeon
make
accur
diagnosi
interpret
integr
differ
test
result
done
caution
singl
solut
address
possibl
everi
modal
limit
furthermor
interpret
test
result
alway
correl
patient
clinic
condit
csf
analys
done
acut
phase
pair
done
convalesc
phase
rel
easi
collect
csf
alway
exclud
contraind
perform
contraind
summar
kneen
et
al
boyl
et
al
first
group
contraind
necessit
imag
lp
includ
follow
chang
level
conscious
coma
consensu
depth
coma
british
guidelin
recommend
prior
imag
indic
glasgow
coma
scale
less
fluctuat
presenc
papilledema
clinician
bear
mind
papilledema
may
take
time
develop
observ
initi
clinic
assess
rel
bradycardia
presenc
hypertens
abnorm
doll
eye
movement
newonset
focal
neurolog
deficit
includ
unequ
dilat
poorli
respons
pupil
level
conscious
normal
isol
cranial
nerv
palsi
howev
regard
contraind
perform
lp
inexplic
seizur
first
stabil
stabil
follow
imag
patient
ventriculoperiton
shunt
situ
immunocompromis
patient
comput
tomographi
ct
scan
reveal
midlin
shift
narrow
basal
cistern
associ
spaceoccupi
lesion
brain
edema
danger
perform
lp
may
precipit
brain
stem
andor
tonsillar
herniat
import
rememb
ct
scan
use
rule
rais
icp
remain
clinic
diagnosi
contraind
lp
includ
underli
coagul
disord
unexplain
bleed
mucou
membran
petechi
rash
expand
purpura
featur
associ
dissemin
intravascular
coagulopathi
although
platelet
count
l
use
cutoff
point
lp
may
still
possibl
care
consider
platelet
count
l
sepsi
area
lp
site
hemodynam
instabl
shock
respiratori
insuffici
lp
perform
patient
must
review
everi
hour
lp
must
perform
soon
contraind
clear
analys
csf
obtain
first
lp
nondiagnost
lp
repeat
hour
later
analys
csf
includ
assess
open
pressur
biochemistri
differ
cell
type
microbiolog
normal
open
pressur
cm
h
normal
mildli
elev
viral
enceph
brain
protect
bbb
therefor
csf
mere
ultrafiltr
plasma
filtrat
across
bbb
contain
water
electrolyt
glucos
protein
mostli
albumin
low
molecular
weight
protein
concentr
csf
low
comparison
serum
normal
condit
albumin
total
protein
serum
major
protein
csf
immunoglobulin
may
present
csf
normal
individu
intact
bbb
case
immunoglobulin
g
igg
total
csf
protein
order
two
third
serum
igg
total
protein
csf
protein
concentr
increas
either
bbb
damag
intrathec
igg
product
occur
variou
indic
help
determin
whether
bbb
intact
ascertain
contribut
intrathec
igg
synthesi
import
serum
csf
sent
analyz
simultan
high
resolut
electrophoresi
isoelectr
focus
techniqu
determin
protein
band
specimen
normal
individu
band
csf
correspond
band
present
serum
intrathec
igg
product
addit
band
detect
csf
two
differ
band
present
known
oligoclon
band
bbb
damag
may
help
creat
addit
band
distinguish
intrathec
igg
product
contribut
igg
serum
might
leak
across
bbb
four
indic
help
provid
tap
traumat
albumin
index
q
alb
igg
index
igg
synthesi
rate
local
igg
synthesi
albumin
produc
intrathec
therefor
ratio
csf
serum
albumin
concentr
q
alb
constant
healthi
individu
less
bbb
damag
albumin
leak
csf
albumin
concentr
increas
q
alb
reflect
degre
damag
almost
total
breakdown
bbb
igg
index
quotient
q
igg
csf
serum
igg
ratio
elev
either
intrathec
igg
product
bbb
damag
q
alb
normal
case
former
elev
case
latter
igg
synthesi
rate
formula
calcul
amount
intrathec
produc
igg
correct
differ
molecular
weight
daili
csf
product
possibl
serum
igg
event
bbb
damag
refer
rang
mgday
fals
elev
level
may
occur
bbb
damag
local
igg
synthesi
calcul
valuabl
diagnost
sensit
high
fals
posit
rate
low
use
determin
minimum
amount
local
synthesi
cn
valu
upper
limit
normal
mg
dl
conjunct
elev
q
igg
strongli
suggest
increas
intrathec
igg
synthesi
biochem
analys
csf
also
includ
lactat
glucos
addit
determin
protein
glucos
compar
plasma
glucos
taken
lp
viralrel
cn
infect
protein
normal
mildli
elev
gl
glucos
ratio
normal
decreas
normal
lactat
normal
albuminocytolog
dissoci
elev
protein
normal
csf
cell
count
strong
marker
acut
chronic
demyelin
polyneuropathi
may
detect
least
week
ill
immun
cell
csf
healthi
person
limit
number
major
cell
memori
cell
cell
group
bcell
natur
killer
cell
dendrit
cell
mast
cell
monocyt
polymorphonuclear
granulocyt
minor
make
immun
cell
csf
leukocytosi
indic
inflammatori
process
composit
cell
chang
constantli
diseas
progress
also
influenc
primari
site
infect
increas
number
leukocyt
like
viral
mening
enceph
primari
site
mening
number
leukocyt
csf
increas
polymorphonuclear
granulocyt
domin
cell
type
earli
diseas
follow
later
monocyt
lymphocyt
enceph
csf
may
normal
two
third
case
sejvar
et
al
defin
csf
pleocytosi
cellsmm
babi
less
month
age
cell
mm
older
infant
children
howev
csf
may
also
complet
acellular
associ
vzv
epsteinbarr
viru
cmv
infect
also
often
observ
immunocompromis
patient
red
blood
cell
rbc
elev
approxim
hse
case
differenti
diagnos
elev
rbc
includ
traumat
tap
subarachnoid
hemorrhag
case
traumat
tap
correct
made
protein
cell
count
although
complic
formula
adjust
anemia
peripher
leukocytosi
avail
onlin
http
referencemedscapecomcalculatorcsfproteinconcentrationcorrect
simplifi
way
correct
influenc
traumat
tap
subtract
one
white
blood
cell
everi
rbcmm
mgdl
protein
everi
rbcmm
microscopi
cultur
sensit
bacteria
perform
csf
sampl
antigen
detect
may
also
help
test
mycobacterium
tuberculosi
alway
consid
endem
area
immunocompromis
patient
specif
virolog
studi
csf
depend
mainli
epidemiolog
advis
keep
store
extra
csf
sampl
specif
investig
indic
viral
cultur
nowaday
play
inferior
role
identif
virus
costli
low
yield
still
use
serotyp
enterovirus
polymeras
chain
reaction
pcr
chang
diagnost
virolog
detect
low
copi
number
high
sensit
detect
virus
diagnost
window
clearli
describ
virus
hsv
despit
csf
specimen
vzv
enterovirus
sent
pcr
patient
suspect
viral
cn
infect
identifi
known
viral
caus
hsv
pcr
often
neg
first
day
onset
diseas
remain
posit
next
day
even
acyclovir
treatment
start
probabl
get
posit
pcr
thu
reduc
sampl
taken
earli
within
day
late
day
cours
diseas
may
worthwhil
defer
initi
lp
two
reason
contraind
lp
due
sever
cerebr
edema
give
time
edema
subsid
pcr
better
diagnost
yield
correl
viral
replic
degre
clinic
sever
possibl
posit
pcr
furthermor
posit
pcr
result
interpret
caution
three
differ
scenario
consid
firstli
primari
infect
secondli
reactiv
latent
infect
thirdli
concomit
infect
may
stimul
reactiv
latent
viru
fact
one
type
viru
brain
simultan
interplay
complic
matter
fals
posit
neg
result
alway
issu
concern
therefor
import
standard
molecular
diagnost
test
illustr
clearli
studi
examin
nine
differ
european
refer
laboratori
found
concord
result
specimen
test
hsv
pcr
wherea
realtim
pcr
specif
almost
sensit
select
addit
microbiolog
investig
direct
clinic
featur
travel
histori
local
epidemiolog
viru
cultur
pcr
sampl
site
use
specif
case
rectal
throat
swab
investig
enterovirus
case
enceph
respiratori
virus
pcr
throat
swab
sputum
indic
patient
recent
respiratori
infect
constant
drive
explor
novel
way
assist
diagnosi
enceph
differenti
infecti
immunemedi
unknown
etiolog
although
detail
discuss
diagnost
valu
role
mediat
cn
infect
fall
beyond
scope
chapter
shown
cytokin
associ
mediat
profil
particularli
differ
csf
patient
underli
infect
immunemedi
patholog
cytokin
polypeptid
messeng
import
regul
varieti
biolog
process
particularli
import
proinflammatori
antiinflammatori
process
four
group
cytokin
identifi
first
group
interleukin
il
involv
innat
immun
second
group
transform
growth
factor
tgf
orchestr
inflammatori
process
third
group
respons
activ
prolifer
lymphocyt
fourth
group
involv
leukocyt
growth
chemokin
specif
cytokin
involv
attract
traffick
cell
four
subgroup
cxc
cc
xc
although
serolog
practic
refer
antibodi
blood
context
cn
viral
infect
csf
antibodi
also
measur
interlink
serolog
diagnosi
viral
infect
serolog
gener
limit
valu
unless
serial
sampl
analyz
serum
csf
result
compar
antibodi
product
dynam
process
take
day
antibodi
becom
posit
initi
antibodi
steadili
rise
peak
product
remain
posit
year
latent
infect
certain
specif
scenario
serolog
benefici
presenc
immunoglobulin
igm
csf
indic
intrathec
antivir
immun
respons
use
rna
virus
flavivirus
usual
primari
infect
mere
reactiv
dna
virusassoci
diseas
serolog
investig
epsteinbarr
viru
arbovirus
use
suspect
caus
cn
infect
case
eastern
equin
enceph
serum
antibodi
test
help
diseas
detect
within
day
onset
increas
fourfold
day
seroconvers
dynam
process
serial
specimen
analyz
result
pair
csf
result
interpret
csf
serolog
discuss
sect
acut
ill
patient
possibl
cn
infect
usual
imag
exclud
possibl
caus
complic
limit
imag
alway
kept
mind
recent
studi
granerod
et
al
show
subject
compon
scan
interpret
matter
complic
fact
imag
data
also
influenc
time
scan
specif
imag
techniqu
factor
directli
influenc
valu
imag
among
diagnost
criteria
enceph
hse
base
radiolog
abnorm
research
area
requir
common
practic
perform
ct
brain
scan
lp
perform
doubt
rel
contraind
lp
perform
overwhelm
brain
edema
swell
midlin
shift
spaceoccupi
lesion
normal
ct
brain
scan
howev
guarante
icp
normal
case
hse
first
ct
scan
may
also
normal
abnorm
detect
followup
scan
ideal
circumst
mri
scan
perform
patient
suspect
enceph
within
hour
admiss
hospit
specif
detail
refer
differ
section
clinic
syndrom
virus
eeg
routin
done
patient
suspect
enceph
use
confirm
encephalopathi
exclud
possibl
psychiatr
condit
altern
reason
associ
behavior
chang
also
import
detect
seizur
activ
subtl
nonconvuls
seizur
seizur
activ
signific
effect
develop
brain
edema
worsen
coma
recent
studi
mohammad
et
al
show
earli
eeg
nonspecif
marker
enceph
high
sensit
patient
studi
abnorm
first
eeg
gener
characterist
eeg
featur
encephalopathi
slow
focal
gener
epileptiform
featur
specif
pattern
also
describ
period
later
epileptiform
discharg
regard
pathognomon
hse
may
also
occur
patient
sspe
earli
reactiv
eeg
background
extrem
spindl
associ
antindmar
enceph
eeg
prognost
valu
enceph
normal
eeg
patient
suspect
enceph
associ
low
rel
risk
death
nonreact
background
eeg
perform
earli
diseas
predict
abnorm
outcom
advis
hiv
must
exclud
everi
patient
enceph
number
reason
patient
may
present
acut
meningoenceph
primari
infect
longstand
encephalopathi
hiv
predispos
patient
rarer
cn
infect
cmv
incid
common
cn
infect
higher
hivinfect
patient
addit
investig
select
request
basi
specif
system
involv
ensur
patient
hemodynam
stabl
treat
hypoglycemia
often
present
viral
enceph
instantli
treat
seizur
rais
icp
accord
standard
protocol
pathogenesi
rais
icp
associ
viral
enceph
differ
context
studi
essenti
investig
efficaci
specif
edemalow
modal
observ
autonom
instabl
result
pend
treatment
administ
without
delay
includ
broadspectrum
antibiot
often
thirdgener
cephalosporin
acyclovir
role
steroid
adjuv
therapi
hse
still
controversi
steroid
thu
administ
routin
result
current
await
multicent
multin
doubleblind
placebocontrol
european
studi
known
german
trial
acyclovir
corticosteroid
hse
empir
treatment
intraven
acyclovir
start
sooner
rather
later
within
hour
hospit
admiss
viral
enceph
strongli
suspect
usual
combin
thirdgener
cephalosporin
possibl
bacteri
mening
two
treatment
categori
neonat
higher
dosag
acyclovir
mgkg
per
dose
hourli
administ
hse
confirm
continu
period
day
children
day
year
acyclovir
start
mgkg
hourli
ivi
continu
day
hse
confirm
lp
repeat
confirm
csf
pcr
neg
hsv
pcr
posit
repeat
lp
acyclovir
continu
pcr
perform
weekli
becom
neg
dose
reduc
patient
renal
impair
next
question
answer
acyclovir
stop
patient
suspect
enceph
neg
hsv
pcr
patient
immunocompet
stop
soon
anoth
diagnosi
confirm
hsv
pcr
neg
two
lp
perform
hour
apart
hsvassoci
characterist
mri
least
hour
onset
diseas
case
lp
defer
reason
acyclovir
start
empir
patient
subsequ
improv
acyclovir
stop
level
conscious
normal
hsv
pcr
mri
perform
hour
symptom
onset
normal
csf
white
blood
cell
count
less
l
altern
simplifi
regim
hse
involv
administ
acyclovir
intraven
mgkg
per
dose
hourli
day
also
suggest
patient
csf
hsv
pcr
neg
confirm
treatment
stop
patient
benefit
second
cours
acyclovir
support
hypothesi
viru
complet
inactiv
may
relat
shorter
cours
acyclovir
given
suppress
acyclovir
treatment
period
month
associ
less
damag
fewer
episod
recurr
like
patient
postinfecti
encephalopathi
benefit
steroid
therapi
rather
acyclovir
oral
acyclovir
use
hse
reach
adequ
level
csf
valacyclovir
use
oral
children
day
intraven
acyclovir
venou
access
becam
problemat
regist
use
children
research
requir
case
vzv
enceph
dose
higher
name
mgkg
hourli
day
age
group
treatment
continu
patient
immunocompromis
vzv
cerebel
requir
treatment
selflimit
diseas
resolv
within
week
vasculopathi
present
corticosteroid
indic
enteroviru
enceph
routin
treat
intraven
immunoglobulin
use
patient
chronic
enteroviru
mening
sever
infect
treatment
protocol
cmv
enceph
well
establish
ganciclovir
foscarnet
cidofovir
studi
openlabel
studi
evid
specif
protocol
still
lack
aggress
treatment
acut
phase
includ
intraven
steroid
plasma
exchang
immunoglobulin
treatment
follow
oral
steroid
corticosteroid
spare
drug
exampl
azathioprin
cyclophosphamid
constant
search
novel
drug
treatment
viralrel
cn
infect
detail
discuss
fall
beyond
scope
chapter
interest
idea
deserv
mention
nucleotidyltransferas
superfamili
enzym
inhibitor
identifi
potenti
novel
treatment
hsv
infect
suppress
replic
viru
signific
advanc
gene
edit
made
includ
three
possibl
strategi
antivir
drug
develop
zincfing
nucleas
transcript
activatorlik
effector
nucleas
cluster
regulatori
interspac
short
palindrom
repeatassoci
nine
system
complic
prognosi
vari
differ
clinic
syndrom
cn
infect
due
virus
mortal
rate
enceph
vari
five
morbid
enceph
adult
report
acut
phase
statu
epilepticu
coma
thrombocytopenia
hyponatremia
result
inappropri
secret
antidiuret
hormon
cerebr
edema
seriou
complic
cerebr
edema
result
direct
viral
infect
enterovirus
known
seizur
activ
seizur
activ
accompani
hypoxia
untreat
convuls
statu
epilepticu
may
contribut
mainten
viciou
cycl
continu
cell
damag
number
studi
identifi
prognost
factor
acut
phase
cerebr
edema
statu
epilepticu
thrombocytopenia
associ
inhospit
mortal
addit
poor
prognost
factor
lower
level
conscious
admiss
hypothermia
elev
csf
protein
presenc
glial
neuroaxon
protein
csf
indic
inflamm
neuron
damag
potenti
biomark
determin
prognosi
lower
qualityoflif
score
found
patient
abnorm
mri
find
admit
seizur
result
epilepsi
normal
eeg
associ
surviv
longterm
outcom
alway
well
describ
quantifi
isra
studi
found
attent
deficit
hyperact
disord
behavior
disord
present
individu
patient
show
residu
motor
deficit
also
document
cognit
affect
longterm
sequela
spastic
epilepsi
movement
disord
feed
difficulti
systemat
review
metaanalysi
khandak
et
al
conclud
almost
children
show
incomplet
recoveri
sequela
development
delay
behavior
disturb
neurolog
complic
includ
seizur
patient
treat
antindmar
enceph
acut
phase
gener
good
outcom
may
experi
complic
chronic
use
immunotherapi
shown
relationship
patient
readmit
acut
ill
develop
neurolog
sequela
well
later
onset
epilepsi
patient
neurolog
sequela
first
foremost
prevent
strategi
avoid
exposur
hygien
import
avoid
protect
vector
includ
wear
protect
cloth
control
breed
site
use
insect
repel
although
insect
repel
alway
effect
anymor
insect
becom
insensit
insecticid
climat
variabl
chang
veget
influenc
surviv
arthropod
second
import
strategi
prevent
cn
viral
infect
vaccin
vaccin
avail
mump
measl
rubella
influenza
japanes
enceph
viru
rabi
tickborn
enceph
viru
group
research
howev
found
current
vaccin
japanes
enceph
viru
may
protect
new
emerg
strain
viru
new
vaccin
enteroviru
proven
success
biggest
threat
success
prevent
vaccin
low
vaccin
coverag
due
religi
belief
mistrust
inadequ
vaccin
program
result
mani
differ
reason
major
vaccin
communic
diseas
exist
use
arbovirus
respons
problem
scientist
investig
differ
innov
strategi
aim
prevent
viru
complet
lifecycl
vector
ultim
prevent
transmiss
human
vaccin
call
transmiss
block
vaccin
one
exampl
dengu
viru
vaccin
protein
requir
mosquito
attach
virion
target
cell
midgut
use
vaccin
antigen
mosquito
feed
vaccin
human
antibodi
ingest
subsequ
impair
virion
attach
mosquito
interrupt
complet
life
cycl
block
transmiss
prevent
infect
vector
type
vaccin
refer
altruist
vaccin
may
protect
person
vaccin
infect
prevent
diseas
spread
member
commun
signific
advanc
made
develop
transmiss
block
vaccin
control
viral
vectorborn
diseas
research
still
requir
specif
characterist
manifest
differ
viral
famili
relev
speci
highlight
section
famili
herpesvirida
larg
famili
doublestrand
dna
virus
speci
commonli
associ
cn
viralrel
diseas
cmv
epsteinbarr
viru
vzv
must
note
test
specif
differenti
lymphotrop
herp
virus
epsteinbarr
viru
cmv
neurotrop
virus
hsv
vzv
vari
much
better
latter
herp
simplex
virus
includ
type
common
caus
sporad
enceph
children
one
treatabl
caus
schleed
et
al
report
multicent
studi
account
hse
case
studi
caus
morbid
mortal
sever
mortal
rate
vari
neonat
affect
predomin
type
nonneon
male
readili
affect
femal
viru
migrat
along
trigemin
olfactori
nerv
brain
caus
hse
predominantli
affect
tempor
frontal
lobe
brain
result
focal
neurolog
sign
hsv
may
remain
latent
dorsal
root
sensori
ganglia
throughout
life
two
third
hse
case
primari
infect
due
reactiv
reinfect
central
chemokin
receptor
relat
ligand
main
role
player
pathogenesi
infect
human
ligand
present
tcell
macrophag
import
leukocyt
migrat
experiment
model
autoimmun
enceph
interact
play
import
role
recruit
tcell
cn
chemokin
elev
trigemin
ganglia
brain
stem
mice
infect
consequ
increas
viral
load
follow
increas
infiltr
respect
area
tumor
necrosi
elev
csf
patient
hse
may
contribut
demyelin
clinic
present
children
hse
vari
de
et
al
summar
eloqu
spectrum
diseas
present
acut
onset
fever
encephalopathi
seizur
focal
sign
subacut
milder
form
also
describ
fever
may
absent
initi
opercular
syndrom
hallmark
dysarthria
dysphagia
orofaci
palsi
may
also
manifest
california
enceph
project
two
age
group
hse
peak
identifi
first
group
includ
younger
children
month
year
second
peak
age
group
year
lethargi
fever
confus
seizur
common
manifest
seizur
observ
commonli
younger
age
group
differ
statist
signific
contrast
adult
children
develop
enceph
primari
hsv
infect
may
affect
herp
labiali
death
observ
project
children
older
year
point
statist
signific
patient
hse
may
find
recur
relaps
may
happen
earli
within
week
diseas
later
month
year
relaps
rate
report
reactiv
viru
trigger
releas
corticosteroid
stress
condit
respons
activ
cjun
ntermin
kinas
pathway
methylationphosphoryl
switch
switch
viral
gene
express
proceed
patient
present
varieti
neurolog
symptom
abnorm
movement
common
present
patient
studi
schleed
et
al
import
clinic
manifest
lethargi
seizur
hemiparesi
cranial
nerv
palsi
patient
may
neg
hsv
pcr
episod
csf
may
normal
patient
protein
may
elev
continu
rise
even
treatment
start
may
even
stay
elev
treatment
stop
california
enceph
project
children
hse
elev
protein
csf
pleocytosi
median
cellsmm
median
rbc
count
three
cellsmm
de
et
al
note
also
polymorphonuclear
cell
may
predomin
earli
diseas
process
diseas
may
mistaken
bacteri
infect
rbc
may
elev
reflect
underli
necrosi
glucos
csf
may
normal
slightli
decreas
patient
schleed
et
al
studi
valu
mmoll
gold
standard
diagnosi
remain
hsv
pcr
pcr
may
neg
initi
becom
posit
lp
repeat
day
later
median
day
onset
symptom
multipl
hypothes
suggest
explain
fals
neg
pcr
one
reason
may
low
viral
load
csf
onset
diseas
link
neg
pcr
low
csf
protein
white
cell
count
also
describ
fluid
vesicl
may
sent
pcr
present
primari
hsv
infect
case
hse
vzv
enceph
skin
lesion
also
true
perior
vesicl
mean
patient
associ
enceph
well
serolog
often
help
confirm
diagnosi
initi
stage
take
week
hsv
igm
produc
intrathec
hsv
igg
detect
csf
day
onset
ill
rise
peak
around
day
may
detect
year
diseas
imag
includ
ct
mri
scan
help
diagnosi
mri
sensit
patient
california
enceph
project
abnorm
mri
find
mri
find
may
nevertheless
normal
although
tempor
lobe
involv
present
patient
extra
tempor
lobe
abnorm
either
associ
tempor
lobe
abnorm
isol
imag
may
demonstr
signal
chang
right
onset
follow
diffusionweight
chang
visibl
day
onset
symptom
contrast
enhanc
mri
becom
posit
period
day
onset
symptom
chang
develop
cours
ill
normal
high
low
necrot
lesion
develop
later
week
onset
symptom
neonat
mri
imag
differ
older
children
pariet
lobe
occipit
lobe
insula
may
affect
frequent
tempor
lobe
diffus
white
matter
lesion
occur
patient
relaps
hse
diagnosi
also
support
eeg
common
find
california
enceph
project
presenc
multifoc
diffus
slow
patient
period
later
epileptiform
discharg
present
case
focal
epileptiform
discharg
identifi
patient
prompt
treatment
limit
morbid
mortal
hse
left
untreat
mortal
rate
patient
may
recov
complet
detail
discuss
treatment
refer
sect
document
immunotherapi
benefici
treatment
autoimmun
posths
highli
contagi
viru
vzv
present
fever
vesicular
exanthema
two
differ
diseas
pattern
recogn
name
chickenpox
primari
infect
shingl
herp
zoster
reactiv
rash
may
preced
cn
infect
may
complet
absent
even
appear
later
cn
involv
one
three
clinic
case
manifest
enceph
vasculopathi
postinfecti
immunemedi
cerebellar
ataxia
latter
often
benign
selflimit
hydrocephalu
may
develop
cerebellum
extens
swollen
around
one
third
arteri
stroke
children
associ
vzv
week
month
rash
patient
present
acuteonset
perman
hemiparesi
clinic
featur
includ
transient
facial
weak
chorea
seizur
visual
speech
disturb
vzv
pcr
may
posit
case
vzv
igg
antibodi
posit
mani
case
recommend
assay
done
csf
igg
level
must
compar
serum
vzv
igg
confirm
intrathec
synthesi
cmv
hhv
largest
genom
affect
mainli
immunocompromis
patient
expand
rang
clinic
manifest
includ
enceph
mening
extens
transvers
myeliti
polyradiculomyel
outcom
highli
variabl
major
site
brain
affect
basal
ganglia
brain
stem
diencephalon
although
astrocyt
commonli
infect
almost
cell
type
cn
involv
congenit
cmv
infect
caus
sever
cerebr
palsi
cognit
impair
sensorineur
deaf
cmv
treat
acyclovir
effect
cn
complic
unclear
two
speci
b
import
pathogen
immunocompet
immunocompromis
patient
common
gener
popul
popul
alreadi
seroconvert
age
year
virus
addit
lymphotrop
neurotrop
featur
abil
integr
telomer
region
chromosom
host
subsequ
transmit
vertic
mendelian
pattern
inherit
via
infect
organ
organ
transplant
transplacent
babi
congenitallyacquir
may
exhibit
inabl
control
exogen
may
suffer
neurolog
symptom
three
stage
diseas
manifest
primari
infect
febril
ill
infant
fussi
rhinorrhea
possibl
enceph
second
stage
children
adult
roseola
infantum
sixth
diseas
common
diseas
childhood
viru
replic
salivari
gland
spread
via
saliva
becom
latent
monocyt
lymphocyt
addit
mening
enceph
diseas
associ
multipl
sclerosi
tempor
lobe
epilepsi
statu
epilepsi
third
stage
due
reinfect
reactiv
viru
immunocompromis
patient
role
pathogenesi
seizur
current
activ
research
mohammadpour
touserkani
et
al
conduct
metaanalys
systemat
review
topic
although
interest
find
potenti
mechan
involv
microgli
cell
oligodendrocyt
immun
regulatori
effect
astrocyt
studi
valid
relationship
requir
howev
clear
may
present
children
febril
seizur
children
febrileassoci
statu
epilepsi
infect
pose
difficulti
diagnos
viral
dna
integr
host
dna
consequ
high
level
dna
detect
csf
blood
plasma
treatment
primari
infect
indic
ganciclovir
foscarnet
may
use
firstli
cidofovir
secondli
reactiv
cn
infect
anoth
consider
bear
mind
fact
unnecessari
use
antibiot
cortison
small
child
fever
skin
rash
may
aggrav
viral
replic
invitro
experi
shown
amoxicillin
carbamazepin
valproat
activ
cortison
increas
viral
load
csf
cn
infect
due
epsteinbarr
viru
account
less
primari
epsteinbarr
viru
infect
epsteinbarr
viru
caus
enceph
encephalomyel
teenag
absenc
typic
infect
mononucleosi
featur
may
also
occur
shortli
infect
mononucleosi
infect
cn
may
also
due
reactiv
postinfecti
immunemedi
respons
visual
hallucin
may
specif
characterist
associ
sign
enceph
outcom
vari
patient
isol
gray
white
matter
lesion
recov
well
almost
half
patient
thalami
affect
residu
effect
highest
mortal
among
patient
brain
stem
involv
john
cunningham
viru
doublestrand
dna
viru
famili
polyomavirida
infect
childhood
common
usual
asymptomat
postul
viru
may
persist
latent
infect
kidney
mononuclear
cell
reactiv
patient
becom
immun
suppress
cerebr
white
matter
serious
affect
patchi
confluent
demyelin
clinic
manifest
includ
rapid
neurocognit
deterior
focal
neurolog
sign
visual
field
defect
ataxia
patient
may
die
within
month
onset
diseas
diagnosi
confirm
csf
pcr
brain
biopsi
flavivirida
singlestrand
rna
virus
tickborn
enceph
viru
japanes
enceph
viru
zika
viru
west
nile
viru
wnv
respons
sever
cn
infect
virus
transmit
tick
mosquito
bite
therefor
also
refer
arbovirus
term
arboviru
acronym
arthropodborn
viru
includ
flavivirus
also
virus
like
chikungunya
viru
famili
togavirida
outbreak
wnv
increas
europ
north
america
rang
anim
model
studi
explain
pathogenesi
although
rang
cytokin
chemokin
involv
identifi
mani
question
remain
unansw
specif
role
play
attract
immun
cell
regul
wnvinduc
inflamm
uniqu
deserv
mention
small
portion
patient
infect
wnv
symptomat
develop
selflimit
flulik
diseas
less
develop
neuroinvas
diseas
clinic
manifest
mening
myeliti
enceph
overlap
syndrom
wors
immunocompromis
patient
use
wnv
pcr
diagnost
purpos
limit
viremia
short
preced
clinic
featur
therefor
serolog
prefer
diagnost
modal
although
dengu
virus
type
one
four
caus
mainli
arthralgia
hemorrhag
diseas
skin
rash
occasion
caus
cn
infect
arbovirus
serolog
test
prefer
clinic
symptom
follow
later
virem
peak
cn
infect
due
tickborn
enceph
viru
common
asia
europ
tickborn
enceph
viru
contract
tick
bite
also
ingest
unpasteur
cow
goat
milk
infect
livestock
incub
period
day
ingest
via
gut
day
tick
bite
major
infect
asymptomat
associ
flulik
symptom
diseas
cours
monoor
biphas
mening
meningoenceph
meningoencephalomyel
well
cardiac
arrhythmia
autonom
instabl
may
occur
siberian
subtyp
associ
chronic
manifest
affect
cognit
function
hear
vision
balanc
may
also
caus
psychiatr
disturb
flaccid
paralysi
mump
viru
measl
viru
well
known
singlestrand
rna
virus
paramyxovirida
famili
encount
children
member
group
may
potenti
affect
cn
hendra
viru
nipah
viru
despit
avail
effect
vaccin
measl
still
account
signific
morbid
mortal
highest
mortal
among
girl
boy
readili
affect
sspe
infect
present
skin
rash
simultan
cellmedi
clearanc
adapt
immun
respons
appear
measl
rna
persist
viru
clear
detect
blood
saliva
urin
lymphoid
tissu
month
viru
spread
across
synaps
neuron
accumul
mutat
infect
becom
chronic
identifi
import
role
player
mous
model
pathogenesi
may
influenc
differ
cn
cell
type
astrocyt
microglia
involv
sever
immunosuppress
present
later
stage
diseas
measl
affect
cn
four
differ
way
name
primari
measl
enceph
postmeasl
enceph
measl
inclus
bodi
enceph
mibe
sspe
mibe
late
manifest
month
acut
episod
measl
immunocompromis
patient
diseas
mechan
mibe
sspe
similar
affect
neuron
oligodendrocyt
frontal
occipit
pariet
cortic
thalami
pon
medulla
result
sever
perivascular
infiltr
neuron
degener
gliosi
unclear
measl
viru
persist
patient
develop
sspe
year
initi
unev
measl
rash
children
develop
sspe
usual
year
old
male
affect
femal
measl
age
month
pose
greatest
risk
develop
sspe
onset
unannounc
hallmark
behavior
chang
neurocognit
declin
movement
disord
often
associ
myoclonu
eeg
pattern
fairli
typic
diseas
rapidli
progress
veget
state
affect
patient
may
die
within
month
year
onset
diseas
apart
sspe
measl
viru
rna
link
rang
condit
name
multipl
sclerosi
paget
diseas
otosclerosi
chronic
activ
hepat
achalasia
chron
diseas
astonish
littl
known
pathogenesi
mump
classic
pictur
bilater
parot
day
incub
case
cn
infect
may
occur
mump
enceph
character
perivascular
demyelin
cerebrum
cerebellum
brain
stem
spinal
cord
basal
ganglia
may
also
affect
children
mump
mening
contrast
caus
mening
increas
mump
enceph
confirm
pcr
csf
serum
saliva
antibodi
provid
support
evid
picornavirida
famili
rna
virus
includ
human
enterovirus
human
parechoviru
respons
cn
infect
sepsislik
ill
children
nomenclatur
may
appear
confus
nonvirologist
four
speci
enteroviru
enterovirusa
enterovirusd
polio
viru
enterovirusc
speci
three
differ
serotyp
number
coxsackiea
virus
also
belong
enterovirusc
nonpolio
enterovirus
enterovirusa
includ
sever
coxsackiea
virus
enterovirusb
includ
coxsacki
virusb
echovirus
enterovirusd
recent
describ
associ
signific
mortal
morbid
coxsacki
coxsacki
virusb
respons
cn
infect
worldwid
associ
high
morbid
mortal
clinic
manifest
vari
includ
mening
enceph
meningoenceph
experiment
work
done
determin
pathogenesi
nonpolio
enteroviru
cn
infect
done
coxsacki
key
element
cell
migrat
across
bcsfb
csf
monocyt
attract
bcell
also
involv
trojan
hors
mechan
addit
coxsacki
infect
neural
stem
cell
thu
viral
presenc
persist
low
yield
posit
enteroviru
pcr
csf
often
higher
yield
throat
swab
stool
specimen
viru
often
persist
stool
week
gastrointestin
infect
therefor
recommend
csf
also
peripher
site
test
vaccin
polioviru
common
caus
anterior
myeliti
respons
syndrom
poliomyel
regard
epidem
develop
world
endem
develop
world
mostli
affect
children
month
year
sinc
enorm
emphasi
initi
world
health
organ
place
erad
vaccineprevent
diseas
includ
poliomyel
although
polioviru
control
great
extent
worldwid
outbreak
report
tajikistan
republ
congo
elsewher
two
polioviru
vaccin
avail
oral
opv
intramuscular
ipv
polioendem
countri
recommend
birth
opv
dose
follow
primari
seri
opv
dose
least
one
ipv
dose
primari
seri
administ
age
week
week
interv
clinic
present
fairli
easi
identifi
patient
present
typic
lower
motor
neuron
symptom
compris
asymmetr
flaccid
paralysi
areflexia
fascicul
wast
sensat
remain
intact
sphincter
function
usual
affect
interest
weak
seldom
progress
febril
ill
subsid
usual
present
human
parechoviru
upper
respiratori
gastrointestin
tract
infect
children
younger
month
old
feed
problem
irrit
clinic
sign
cn
involv
usual
associ
fever
extens
subcort
white
matter
involv
observ
neonat
enceph
meningotheli
vascular
smooth
muscl
affect
propos
underli
mechan
fatal
leukoencephalopathi
exact
pathogenesi
human
parechoviru
yet
explain
hiv
abl
affect
cn
numer
way
cn
manifest
associ
hiv
often
collect
refer
hivassoci
neurocognit
disord
primari
infect
dual
attack
take
place
bbb
disrupt
cn
invad
via
trojan
hors
mechan
virus
migrat
within
leukocyt
area
reach
antiretrovir
drug
viru
persist
replic
caus
longterm
chronic
diseas
continu
process
monocyt
migrat
enhanc
express
hiv
monocyt
increas
level
csf
subsequ
migrat
monocyt
cn
mandatori
test
everi
patient
present
suspect
viral
enceph
hiv
detail
discuss
hiv
fall
beyond
scope
chapter
rabi
transmit
infect
dog
bat
bite
also
inhal
droplet
infect
donor
organ
open
wound
lick
dog
infect
rabi
rabi
alway
consid
child
rapid
progress
enceph
incub
period
vari
week
year
averag
month
may
difficult
link
diseas
specif
contact
either
bat
infect
anim
prodrom
stage
nonspecif
fever
malais
headach
nausea
vomit
characterist
featur
paresthesia
pain
point
entri
diseas
cours
rapid
specif
symptom
includ
hypersaliv
agit
hydrophobia
signific
neck
stiff
develop
follow
coma
subsequ
death
within
week
diagnosi
reli
serum
csf
serolog
immunohistochemistri
skin
may
help
postexposur
manag
import
includ
wound
treatment
vaccin
immunoglobulin
well
prophylaxi
contact
minim
risk
secondari
transmiss
death
almost
prevent
adequ
postexposur
prophylaxi
appli
chikungunya
viru
singlestrand
rna
viru
genu
alphaviru
three
differ
genotyp
genotyp
associ
region
origin
west
africa
eastcentralsouth
africa
asia
sever
epidem
viru
report
cn
alway
affect
involv
document
patient
present
enceph
chikungunya
viru
gain
access
cn
olfactori
nerv
although
data
form
mous
model
indic
upregul
antiinflammatori
respons
immunosuppress
effect
understand
neuropathogenesi
chikungunya
viru
still
unclear
rotaviru
famili
reovirida
respiratori
syncyti
viru
famili
pneumovirida
associ
enceph
controversi
effect
cn
rarer
caus
adenoviru
erythroviru
lymphocyt
choriomening
viru
rubella
viru
influenza
virus
influenza
virus
famili
orthomyxovirida
wide
rang
clinic
present
vari
mild
enceph
adem
posterior
revers
encephalopathi
syndrom
malign
brain
edema
syndrom
acut
necrot
encephalopathi
acut
necrot
encephalopathi
associ
influenza
occur
young
japanes
children
genet
predisposit
autosom
domin
mutat
identifi
patient
sever
encephalopathi
involv
thalami
brain
stem
white
matter
influenza
viru
may
caus
encephalopathi
focal
neurolog
sign
aphasia
eeg
abnorm
varieti
virus
differ
famili
togeth
viral
tropism
success
manifest
extend
spectrum
complex
clinic
syndrom
influenc
individu
immun
respons
host
constantli
chang
environ
affect
global
natur
disast
war
avail
influenc
health
care
servic
increas
popul
densiti
although
outcom
viral
enceph
vari
morbid
mortal
signific
prompt
treatment
antivir
treatment
may
alter
outcom
usual
start
empir
viral
enceph
suspect
effect
hsv
lesser
extent
vzv
aggress
treatment
immun
modul
drug
success
autoimmunemedi
encephalitid
valu
routin
use
steroid
viral
enceph
clear
prevent
import
aspect
viru
manag
drive
develop
new
vaccin
ongo
import
viral
etiolog
alway
consid
sever
ill
child
cn
manifest
